| Shannon Michelle Novosad Verma, MD | |
|
5300 Far Hills Avenue, Dayton, OH 45429-2347 | |
| (937) 433-7536 | |
| (937) 433-9612 |
| Full Name | Shannon Michelle Novosad Verma |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 5300 Far Hills Avenue, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689771933 | NPI | - | NPPES |
| 2130350 | Other | OH | CIGNA |
| 9624134 | Other | OH | AETNA |
| 000000571667 | Other | OH | ANTHEM BC/BS |
| P00640612 | Other | OH | RAILROAD MEDICARE |
| 2927826 | Other | OH | UNITED HEALTHCARE |
| 1900423 | Other | OH | COVENTRY HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35.090812 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatologists Of Southwestern Ohio, Llc | 7113973041 | 84 |
News Archive
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).
GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, today announced that it has been awarded Phase I of a Fast Track Small Business Innovation Research Grant from the National Institutes of Health to enable enhanced data access and cohort construction for biorepositories.
Orthovita, Inc., an orthobiologics and biosurgery company, reported financial results for the quarter ended June 30, 2010. Product sales for the second quarter of 2010 were $23.9 million compared to $24.5 million for the second quarter of 2009. Product sales for the second quarter of 2009 included $0.6 million from the sale of Vitomatrix™, a bone graft material used in dental products. There were no Vitomatrix sales in the second quarter of 2010 and no further sales of Vitomatrix are currently expected.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 3 days ago
| Entity Name | Dermatologists Of Southwestern Ohio, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801819883 PECOS PAC ID: 7113973041 Enrollment ID: O20050323001436 |
News Archive
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).
GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, today announced that it has been awarded Phase I of a Fast Track Small Business Innovation Research Grant from the National Institutes of Health to enable enhanced data access and cohort construction for biorepositories.
Orthovita, Inc., an orthobiologics and biosurgery company, reported financial results for the quarter ended June 30, 2010. Product sales for the second quarter of 2010 were $23.9 million compared to $24.5 million for the second quarter of 2009. Product sales for the second quarter of 2009 included $0.6 million from the sale of Vitomatrix™, a bone graft material used in dental products. There were no Vitomatrix sales in the second quarter of 2010 and no further sales of Vitomatrix are currently expected.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Michelle Novosad Verma, MD 10708 Country Walk Ct., Centerville, OH 45458 Ph: () - | Shannon Michelle Novosad Verma, MD 5300 Far Hills Avenue, Dayton, OH 45429-2347 Ph: (937) 433-7536 |
News Archive
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).
GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, today announced that it has been awarded Phase I of a Fast Track Small Business Innovation Research Grant from the National Institutes of Health to enable enhanced data access and cohort construction for biorepositories.
Orthovita, Inc., an orthobiologics and biosurgery company, reported financial results for the quarter ended June 30, 2010. Product sales for the second quarter of 2010 were $23.9 million compared to $24.5 million for the second quarter of 2009. Product sales for the second quarter of 2009 included $0.6 million from the sale of Vitomatrix™, a bone graft material used in dental products. There were no Vitomatrix sales in the second quarter of 2010 and no further sales of Vitomatrix are currently expected.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 3 days ago
Dr. Samia W Borchers, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5727 Far Hills Ave, Dayton, OH 45429 Phone: 937-435-4977 Fax: 937-435-0377 | |
Thomas George Olsen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7835 Paragon Rd, Dayton, OH 45459 Phone: 937-434-2351 Fax: 937-434-1381 | |
Rocco Thomas Serrao, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5300 Far Hills Avenue, Dayton, OH 45429 Phone: 937-433-7536 Fax: 937-433-9612 | |
Dr. Rishi Kumar Gandhi, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 999 Brubaker Dr Ste 3, Dayton, OH 45429 Phone: 937-668-9850 Fax: 937-668-8668 | |
Phillip K. Hall, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5300 Far Hills Ave., Dayton, OH 45429 Phone: 937-433-7536 Fax: 937-433-9612 | |
Dr. Jason Scott Ballin, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5300 Far Hills Ave, Dayton, OH 45429 Phone: 937-312-3820 | |
Eugene Brent Kirkland, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5300 Far Hills Avenue, Dayton, OH 45429 Phone: 937-291-8814 Fax: 937-433-4043 |